Work

Strategic evolution of drug discovery modalities: Tanabe Pharma’s approach to immunology and oncology

Year: 2026

Type: article

Source: Folia Pharmacologica Japonica

DOI: 10.1254/fpj.25100

Author: Ryuichi Totsuka

Institution: Tanabe Pharma Corporation (Japan)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160151682

FWCI:

Cites: 9

Cited by:

Related to: